The 2014 American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo is underway in Chicago, IL July 27-31— bringing together members of the laboratory community to exhibit new products and discuss trends in the industry.
MedMira, Inc. is one such company that is showcasing its full Multiplo line for the first time at the AACC. MedMira is expanding its Multiplo product line with the addition of three new multiplex tests that deliver instant, simultaneous, single-cartridge results for syphilis (TP), HIV, and hepatitis C. The new tests being added to the product range include Multiplo TP/nTP, which detects both active and historic syphilis infections, Multiplo TP/HIV/nTP, and Multiplo TP/HIV/HCV, which simultaneously detects syphilis, HIV and hepatitis C.
The new tests all deliver instant results for syphilis infection, a disease with an increasing global prevalence rate. Multiplo TP/nTP and Multiplo TP/HIV/nTP take testing a step further, providing comprehensive screening and confirmatory results for both present and past syphilis infections. Detecting the presence of both current and previous infections provides critical information to help healthcare providers in determining the right course of treatment for their patients.
“The WHO has identified syphilis as a serious global healthcare issue and our Multiplo tests will prove invaluable in large scale testing programs targeting multiple diseases, especially prenatal maternal initiatives. Multiplo TP/HIV is currently under evaluation as part of the WHO prequalification program and we look forward to working with them to bring our newest Multiplo tests to screening programs around the world,” says Kevin Jones, Senior Director Sales & Marketing, MedMira. Learn more about MedMira’s Multiplo line.
Read more
